JPH08505157A - 局所麻酔薬の投与による気管支ぜん息の処置のための方法 - Google Patents
局所麻酔薬の投与による気管支ぜん息の処置のための方法Info
- Publication number
- JPH08505157A JPH08505157A JP6518086A JP51808694A JPH08505157A JP H08505157 A JPH08505157 A JP H08505157A JP 6518086 A JP6518086 A JP 6518086A JP 51808694 A JP51808694 A JP 51808694A JP H08505157 A JPH08505157 A JP H08505157A
- Authority
- JP
- Japan
- Prior art keywords
- local anesthetic
- eosinophil
- lidocaine
- bronchial asthma
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.気管支ぜん息を処置するための方法であって、気管支ぜん息に冒されたヒ トの呼吸管に好酸球活性サイトカインの活性を阻害することによってその気管支 ぜん息の症状を中和するのに有効な量の局所麻酔薬を投与することを含んで成る 方法。 2.前記局所麻酔薬をスプレー又は噴霧により前記ヒトの呼吸管に投与する、 請求項1記載の方法。 3.前記局所麻酔薬を薬学的に許容される液状ビヒクルと組合せて投与する、 請求項2記載の方法。 4.前記局所麻酔薬を毎日約0.05〜15mg/kgの投与量で投与する、請求項1記 載の方法。 5.前記局所麻酔薬がN−アリールアミド又はその薬理学的に許容される塩で ある、請求項1記載の方法。 6.前記局所麻酔薬がアミノアルキルベンゾエート又はその薬理学的に許容さ れる塩である、請求項1記載の方法。 7.前記局所麻酔薬がアミノ−置換化(C1−C5)カルボン酸のN−(C7− C22)アクリルアミド又はその薬理学的に許容される塩である、請求項5記載の 方法。 8.前記局所麻酔薬が脂肪族(C1−C5)カルボン酸のN−〔(モノ−又はジ −(C4−C4)アルキル)フェニル〕アミドであり、その酸が(R)(R′)N −(式中、RはH又は(C1−C5)アルキルであり、そしてR′は(C1−C5) アルキルである)である;又はその薬理学的に許容される塩である、請求項7記 載の方法。 9.前記局所麻酔薬がリドカイン、プリロカイン又はエチドカイン及びその薬 理学的に許容される塩である、請求項8記載の方法。 10.前記局所麻酔薬がリドカイン又はリドカイン塩酸塩である、請求項9記載 の方法。 11.前記局所麻酔薬が、次の一般式のカルボン酸: (R2)(R3)ArC02H (式中、ArはC6H3であり、そしてR2及びR3はそれぞれ、H、ハロ、(R′) (H)N−(ここでR′は(C1−C5)アルキル、H2N−又は(C2C5)アルコ キシである)である)と次の一般式のアルコール (R4)(R5)N(X)OH (式中、Xは(C1−C5)枝分れ又は直鎖アルキレンであり、R4はHもしく は(C1−C4)アルキルであり、R5は(C1−C4)アルキルであるか、又はR4 及びR5は一緒になって5−もしくは6−員複素環式脂肪環であってよく、任意 的に(C1−C3)アルキルにより置換されているか、又は更なる環O−もしくは N−原子を含んで成る)とのエステル、及びその薬理学的に許容される塩である 、請求項6記載の方法。 12.前記局所麻酔薬がプロカイン、クロロプロカイン、ジクロニン、テトラカ イン、ベノキシネート、プロパラカイン、メプリルカイン、ピペロカイン又はそ の薬理学的に許容される塩である、請求項11記載の方法。 13.前記局所麻酔薬がブピバカイン、ジブカイン又は薬理学的に許容される塩 である、請求項1記載の方法。 14.包装材料と、その包装材料の中に収容された複数の単位投与形態の局所麻 酔薬とを含んで成るキットであって、ここで前記包装材料が更に、気管支ぜん息 を処置するようにヒト患者に前記単位投与形態を投与することを指示する仕様手 段をその中に又はそれに取付けられて含んで成る、キット。 15.前記局所麻酔薬が薬理学的に許容される担体と組合されている、請求項14 記載のキット。 16.前記薬理学的に許容される担体が液状ビヒクルである、請求項15記載のキ ット。 17.前記包装材料が噴霧器を含んで成る、請求項14記載のキット。 18.前記包装材料が計量投与吸入器を含んで成る、請求項14記載のキット。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/012,343 | 1993-02-02 | ||
US08/012,343 US5510339A (en) | 1993-02-02 | 1993-02-02 | Method for the treatment of bronchial asthma by administration of topical anesthetics |
PCT/US1994/000901 WO1994017790A1 (en) | 1993-02-02 | 1994-01-25 | Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001017379A Division JP2001192334A (ja) | 1993-02-02 | 2001-01-25 | 局所麻酔薬の投与による好酸球関連疾患の処置のための医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH08505157A true JPH08505157A (ja) | 1996-06-04 |
Family
ID=21754520
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6518086A Pending JPH08505157A (ja) | 1993-02-02 | 1994-01-25 | 局所麻酔薬の投与による気管支ぜん息の処置のための方法 |
JP2001017379A Pending JP2001192334A (ja) | 1993-02-02 | 2001-01-25 | 局所麻酔薬の投与による好酸球関連疾患の処置のための医薬組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001017379A Pending JP2001192334A (ja) | 1993-02-02 | 2001-01-25 | 局所麻酔薬の投与による好酸球関連疾患の処置のための医薬組成物 |
Country Status (12)
Country | Link |
---|---|
US (2) | US5510339A (ja) |
EP (1) | EP0682514B1 (ja) |
JP (2) | JPH08505157A (ja) |
AT (1) | ATE205389T1 (ja) |
AU (1) | AU685777B2 (ja) |
CA (1) | CA2155200C (ja) |
DE (1) | DE69428268T2 (ja) |
DK (1) | DK0682514T3 (ja) |
ES (1) | ES2164097T3 (ja) |
NZ (1) | NZ261990A (ja) |
PT (1) | PT682514E (ja) |
WO (1) | WO1994017790A1 (ja) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589156A (en) * | 1994-05-02 | 1996-12-31 | Henry; Richard A. | Prilocaine and hydrofluourocarbon aerosol preparations |
US5660835A (en) * | 1995-02-24 | 1997-08-26 | East Carolina University | Method of treating adenosine depletion |
US20020032160A1 (en) * | 1995-02-24 | 2002-03-14 | Nyce Jonathan W. | Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels |
US5928883A (en) * | 1996-11-13 | 1999-07-27 | Mayo Foundation For Medical Education | Eosinophil granole proteins as indicators of inflammatory bowel disorders |
US6071910A (en) * | 1996-12-05 | 2000-06-06 | Mayo Foundation For Medical Education And Research | Use of agents to treat eosinophil-associated pathologies |
US5837713A (en) * | 1997-02-26 | 1998-11-17 | Mayo Foundation For Medical Education And Research | Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids |
US5881720A (en) * | 1997-04-29 | 1999-03-16 | The Procter & Gamble Company | Method of delivering halotherapy |
ES2219905T3 (es) * | 1997-08-27 | 2004-12-01 | President And Fellows Of Harvard College | Composiciones para mejorar la curacion de las heridas. |
US6598603B1 (en) * | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
AU3370099A (en) * | 1998-03-31 | 1999-10-18 | Mayo Foundation For Medical Education And Research | Use of platelet activating factor (paf) inhibitors to inhibit il-5 induced eosinophil activation or degranulation |
US6172053B1 (en) | 1999-02-24 | 2001-01-09 | Ruben G. Fabunan | Injection viral treatment |
US6576224B1 (en) | 1999-07-06 | 2003-06-10 | Sinuspharma, Inc. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
AU7847800A (en) * | 1999-10-15 | 2001-04-30 | Mayo Foundation For Medical Education And Research | Topical anesthetics useful for treating cancer, autoimmune diseases and ischemia |
WO2001028543A1 (en) * | 1999-10-15 | 2001-04-26 | Mayo Foundation For Medical Education And Research | TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-δ ACTIVITY |
CA2292902C (en) * | 1999-12-24 | 2012-12-18 | Alain Cadieux | Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases |
US20020046357A1 (en) * | 1999-12-28 | 2002-04-18 | Jiandong Huang | Software-based fault tolerant networking using a single LAN |
US6846486B1 (en) * | 2000-02-24 | 2005-01-25 | Advanced Biotherapy Concepts, Inc. | Method of treating allergy by administering an anti-histamine antibody |
AU7138601A (en) * | 2000-06-23 | 2002-01-08 | Mayo Foundation | Methods of treating neutrophil-related diseases with topical anesthetics |
USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
US8541021B2 (en) * | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US8206738B2 (en) | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US20050113510A1 (en) | 2001-05-01 | 2005-05-26 | Feldstein Mikhail M. | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
RU2286801C2 (ru) * | 2001-05-01 | 2006-11-10 | Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук | Двухфазные биоадгезионные композиции, абсорбирующие воду |
US8728445B2 (en) | 2001-05-01 | 2014-05-20 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences | Hydrogel Compositions |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
CA2446060A1 (en) * | 2001-05-07 | 2002-11-14 | Corium International | Compositions and delivery systems for administration of a local anesthetic agent |
US20040076671A1 (en) * | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
AU2003295769A1 (en) | 2002-11-21 | 2004-06-18 | Ira Sanders | Treatment of mammalian reaction to ige interactions |
US20050119340A1 (en) * | 2003-06-13 | 2005-06-02 | David Anderson | Treatment methods with low-dose, longer-acting formulations of local anesthetics and other agents |
AU2004311478A1 (en) | 2003-12-31 | 2005-07-21 | Cydex Pharmaceuticals, Inc. | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
CA2554649C (en) | 2004-01-30 | 2015-10-27 | Corium International, Inc. | Rapidly dissolving film for delivery of an active agent |
ATE446581T1 (de) * | 2004-03-12 | 2009-11-15 | Trinity College Dublin | Magnetoresistives medium |
JPWO2005102313A1 (ja) * | 2004-04-21 | 2007-08-16 | 協和醗酵工業株式会社 | 慢性副鼻腔炎の予防および/または治療剤 |
EP1791575B1 (en) * | 2004-08-05 | 2014-10-08 | Corium International, Inc. | Adhesive composition |
WO2006065722A2 (en) * | 2004-12-16 | 2006-06-22 | Advanced Inhalation Research, Inc. | Compositions and methods for pulmonary conditions |
US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
US20070178049A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
EP1988878A2 (en) * | 2006-02-15 | 2008-11-12 | Tika Läkemedel AB | Sterilization of corticosteroids with reduced mass loss |
WO2007136707A2 (en) * | 2006-05-17 | 2007-11-29 | University Of Utah Research Foundation | Methods and compositions related to eosinophil regulation |
WO2009006688A1 (en) * | 2007-07-11 | 2009-01-15 | Medvet Science Pty Ltd | Regulating il-4 and il- 13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor |
US8784879B2 (en) | 2009-01-14 | 2014-07-22 | Corium International, Inc. | Transdermal administration of tamsulosin |
RU2446839C1 (ru) * | 2010-08-13 | 2012-04-10 | Государственное учреждение Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского (ГУ МОНИКИ им. М.Ф. Владимирского) | Способ комплексного лечения больных с воспалительными заболеваниями придаточных пазух носа |
US9636425B2 (en) * | 2012-09-18 | 2017-05-02 | Focal Point Technologies, Llc | Method of dry dye delivery for staining the eye |
WO2016205172A1 (en) * | 2015-06-15 | 2016-12-22 | Banner Life Sciences Llc | Soft lozenges comprising corticosteroids |
US9867834B2 (en) * | 2015-06-15 | 2018-01-16 | Banner Life Sciences Llc | Non-systemic topical compositions comprising corticosteroids |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3385M (fr) * | 1963-12-02 | 1965-06-21 | Sobio Lab | Compositions thérapeutiques a base d'ascorbate de procaine. |
US4626530A (en) * | 1981-06-23 | 1986-12-02 | Schulte Thomas L | Treatment of eye inflammation with biphenamine |
US4466973A (en) * | 1983-02-01 | 1984-08-21 | Thomas Rennie | Method of treating nasal and sinus congestion |
US4748022A (en) * | 1985-03-25 | 1988-05-31 | Busciglio John A | Topical composition |
US5134166A (en) * | 1988-12-02 | 1992-07-28 | Genderm Corporation | Method for treating nasal disorders and headaches |
-
1993
- 1993-02-02 US US08/012,343 patent/US5510339A/en not_active Expired - Lifetime
-
1994
- 1994-01-25 EP EP94907887A patent/EP0682514B1/en not_active Expired - Lifetime
- 1994-01-25 PT PT94907887T patent/PT682514E/pt unknown
- 1994-01-25 DK DK94907887T patent/DK0682514T3/da active
- 1994-01-25 AU AU61282/94A patent/AU685777B2/en not_active Ceased
- 1994-01-25 JP JP6518086A patent/JPH08505157A/ja active Pending
- 1994-01-25 AT AT94907887T patent/ATE205389T1/de not_active IP Right Cessation
- 1994-01-25 DE DE69428268T patent/DE69428268T2/de not_active Expired - Lifetime
- 1994-01-25 ES ES94907887T patent/ES2164097T3/es not_active Expired - Lifetime
- 1994-01-25 NZ NZ261990A patent/NZ261990A/xx unknown
- 1994-01-25 WO PCT/US1994/000901 patent/WO1994017790A1/en active IP Right Grant
- 1994-01-25 CA CA002155200A patent/CA2155200C/en not_active Expired - Fee Related
-
1996
- 1996-03-20 US US08/618,860 patent/US5631267A/en not_active Expired - Lifetime
-
2001
- 2001-01-25 JP JP2001017379A patent/JP2001192334A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0682514B1 (en) | 2001-09-12 |
US5631267A (en) | 1997-05-20 |
ATE205389T1 (de) | 2001-09-15 |
CA2155200A1 (en) | 1994-08-18 |
US5510339A (en) | 1996-04-23 |
DK0682514T3 (da) | 2002-01-14 |
AU685777B2 (en) | 1998-01-29 |
WO1994017790A1 (en) | 1994-08-18 |
ES2164097T3 (es) | 2002-02-16 |
NZ261990A (en) | 1997-08-22 |
CA2155200C (en) | 2006-12-19 |
EP0682514A1 (en) | 1995-11-22 |
JP2001192334A (ja) | 2001-07-17 |
DE69428268D1 (de) | 2001-10-18 |
PT682514E (pt) | 2002-03-28 |
AU6128294A (en) | 1994-08-29 |
DE69428268T2 (de) | 2002-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH08505157A (ja) | 局所麻酔薬の投与による気管支ぜん息の処置のための方法 | |
US5837713A (en) | Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids | |
WO1994017790A9 (en) | Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma | |
US7816374B2 (en) | Method of treating neutrophil-related diseases with topical anesthetics | |
AU781177B2 (en) | Novel combination of non-sedative anti-histamines containing substances which influence the action of leukotriene, for treating rhinitis/conjunctivitis | |
CA2466338C (en) | New uses for anti-malarial therapeutic agents | |
KR20050104367A (ko) | 타 활성제와 결합하여 장기 효능을 지속하는 베타2-동근으로 구성되는 약물 | |
AU2001271386A1 (en) | Methods of treating neutrophil-related diseases with topical anesthetics | |
JP2014525471A (ja) | 咳および咳発作の治療 | |
AU2002363443A1 (en) | New uses for anti-malarial therapeutic agents | |
US6572858B1 (en) | Uses for anti-malarial therapeutic agents | |
US6071910A (en) | Use of agents to treat eosinophil-associated pathologies | |
JPH0222733B2 (ja) | ||
US9539221B2 (en) | Method of treating airway diseases with β-adrenergic inverse agonists | |
JP2003534298A (ja) | 咳の新規治療法 | |
EP1101496A1 (en) | Therapeutic agents for allergic diseases | |
WO2022162992A1 (ja) | アレルギー治療のための医薬組成物 | |
Beech | Drug therapy of respiratory disorders | |
AU4584702A (en) | Treatment of eosinophil-associated pathologies such as bronchial asthma with synergistic combinations of glucocorticoids and a local anesthetics | |
MXPA01000561A (en) | Therapeutic agents for allergic diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040525 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040824 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20041004 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041125 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060425 |